MA38007B1 - Formulations liquides d'apixaban - Google Patents

Formulations liquides d'apixaban

Info

Publication number
MA38007B1
MA38007B1 MA38007A MA38007A MA38007B1 MA 38007 B1 MA38007 B1 MA 38007B1 MA 38007 A MA38007 A MA 38007A MA 38007 A MA38007 A MA 38007A MA 38007 B1 MA38007 B1 MA 38007B1
Authority
MA
Morocco
Prior art keywords
apixaban
liquid formulations
liquid formulation
liquid
administering
Prior art date
Application number
MA38007A
Other languages
English (en)
Other versions
MA38007A1 (fr
Inventor
Sherif Ibraham Farag Badawy
Susan Lum
Original Assignee
Bristol Myers Squibb Co
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2013/062051 external-priority patent/WO2014052678A1/fr
Application filed by Bristol Myers Squibb Co, Pfizer filed Critical Bristol Myers Squibb Co
Publication of MA38007A1 publication Critical patent/MA38007A1/fr
Publication of MA38007B1 publication Critical patent/MA38007B1/fr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne une formulation liquide d'apixaban. On décrit également un procédé d'administration d'une formulation liquide d'apixaban.
MA38007A 2012-09-26 2015-04-16 Formulations liquides d'apixaban MA38007B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261705943P 2012-09-26 2012-09-26
PCT/US2013/062051 WO2014052678A1 (fr) 2012-09-26 2013-09-26 Formulations liquides d'apixaban

Publications (2)

Publication Number Publication Date
MA38007A1 MA38007A1 (fr) 2016-02-29
MA38007B1 true MA38007B1 (fr) 2016-10-31

Family

ID=55662163

Family Applications (1)

Application Number Title Priority Date Filing Date
MA38007A MA38007B1 (fr) 2012-09-26 2015-04-16 Formulations liquides d'apixaban

Country Status (1)

Country Link
MA (1) MA38007B1 (fr)

Also Published As

Publication number Publication date
MA38007A1 (fr) 2016-02-29

Similar Documents

Publication Publication Date Title
PH12015500850A1 (en) Stable preservative-free mydriatic and anti-inflammatory solutions for injection
EA201491362A1 (ru) Анестезирующие соединения и способы их применения
EA201591403A1 (ru) Спиролактамные модуляторы рецептора nmda и их применение
IN2012DN06720A (fr)
MX2015003653A (es) Derivados de amida del acido benzoimidazol-carboxilico como moduladores del receptor apj.
IN2015DN00137A (fr)
BR112015000229A2 (pt) formulações aquosas estáveis de etanercept
BR112014009087A2 (pt) formulações de etanercept estabilizadas com xilitol
PH12015500590B1 (en) Apixaban liquid formulations
EA201590200A1 (ru) Модуляторы пути активации комплемента и их применение
BR112014031310A2 (pt) anticorpos anti-pcsk9, formulações, dosagem e métodos de uso
EA201492023A1 (ru) Регуляторы пути комплемента и их применение
EA201400771A1 (ru) Новые производные азетидина, фармацевтические композиции и их применение
EP4360621A3 (fr) Formulations de bendamustine
BR112012029595A2 (pt) spray nasal líquido contendo naltrexona de baixa concentração
MY168212A (en) A new therapeutical composition containing apomorphine as active ingredient
MX347373B (es) Soluciones anti-inflamatorias estables para inyección.
UY33490A (es) Ésteres de quinolina nuevos útiles para el tratamiento de trastornos cutáneos.
EA201590193A1 (ru) Препараты лаквинимода без подщелачивающего агента
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
PE20150190A1 (es) Formulacion farmaceutica
CR20130318A (es) Nuevos compuestos de benzodioxol-piperazina
CR20130591A (es) Composición farmacéutica que comprende fexofenadina
MA38007B1 (fr) Formulations liquides d'apixaban
MX368640B (es) Composición farmacéutica para tratar inflamación y dolor.